Based on the Vicarious Surgical Inc. stock forecast from 3 analysts, the average analyst target price for Vicarious Surgical Inc. is USD 0.67 over the next 12 months. Vicarious Surgical Inc.’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Vicarious Surgical Inc. is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Vicarious Surgical Inc.’s stock price was USD 0.279. Vicarious Surgical Inc.’s stock price has changed by -14.68% over the past week, -24.80% over the past month and -87.14% over the last year.
No recent analyst target price found for Vicarious Surgical Inc.
No recent average analyst rating found for Vicarious Surgical Inc.
Company Overview Vicarious Surgical Inc.
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts. Read Less
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was founded in 20...Read More
Frequently Asked Questions About Vicarious Surgical Inc. (RBOT) Stock
Based on ratings from 3 analysts Vicarious Surgical Inc.'s stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on RBOT's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for RBOT is USD 0.67 over the next 12 months. The maximum analyst target price is USD 1 while the minimum anlayst target price is USD 0.4.
RBOT stock's Price/Earning ratio is 50.00.
Our analysis grades RBOT stock's Price / Earning ratio at F. This means that RBOT stock's Price/Earning ratio is above 57.00000000000001% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this RBOT may be a overvalued for its sector.
The last closing price of RBOT's stock was USD 0.28.
The most recent market capitalization for RBOT is USD 0.06B.
Based on targets from 3 analysts, the average taret price for RBOT is projected at USD 0.67 over the next 12 months.
This means that RBOT's stock price may go up by +138.95% over the next 12 months.
Following are ETFs with the highest allocation to Vicarious Surgical Inc.'s stock :
As per our most recent records Vicarious Surgical Inc. has 131 Employees.
Vicarious Surgical Inc.'s registered address is 78 Fourth Avenue, Waltham, MA, United States, 02451.
You can get more information about it from Vicarious Surgical Inc.'s website at https://www.vicarioussurgical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RBOT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
